Skip to main content
. 2018 Mar 14;9:1087. doi: 10.1038/s41467-018-03430-6

Table 1.

Diabetic platelets do not express increased basal levels of αIIbβ3 or display enhanced responses to soluble agonist stimulation

Agonist (µM) Non-DM DM Significance
Integrin αIIbβ3 expression Untreated 179.8 ± 4.52 203.3 ± 30.9 NS
Untreated (human) 394.5 ± 24.6 488.2 ± 49.6 NS
Integrin αIIbβ3 activation (JON/A binding) Untreated 5.67 ± 0.88 4.67 ± 0.67 NS
ADP (1) 26.98 ± 1.21 27.57 ± 2.94 NS
ADP (10) 111.2 ± 15.8 102.7 ± 19.6 NS
PAR-4 AP (100) 14.67 ± 1.20 24.33 ± 5.23 NS
PAR-4 AP (300) 82.33 ± 3.71 71.33 ± 1.76 NS
P-selectin expression PAR-4 AP (100) 27.57 ± 2.90 30.11 ± 4.82 NS
PAR-4 AP (300) 50.48 ± 2.34 46.88 ± 4.69 NS
P-selectin expression (isolated platelets) PAR-4 AP (100) 23.01 ± 2.17 28.22 ± 4.92 NS
PAR-4 AP (300) 54.36 ± 5.55 49.19 ± 5.42 NS
Aggregation (% maximal) ADP (1) 42.4 ± 1.4 41.6 ± 3.4 NS
ADP (10) 59.3 ± 2.9 57.0 ± 10.0 NS

To assess integrin αIIbβ3 expression (Leo.F2 binding for mouse and HIP8 binding for human), activation (JON/A binding) and P-selectin expression in non-DM and DM platelets (mouse, if not stated otherwise), hirudinated whole blood (1/20 diluted, if not stated otherwise) or isolated washed platelets were stimulated with the indicated concentrations of ADP or PAR-4 activating peptide (PAR4-AP) for 10 min, in the presence of PE-JON/A Ab or FITC-anti-P-selectin Ab, respectively, then subjected to flow cytometry. Results are expressed as the geometric mean of fluorescence intensity. For platelet aggregation, platelet rich plasma from non-DM and DM mice were subjected to aggregometry using 1 or 10 µM ADP. Results are expressed as maximal extent of platelet aggregation (%). All results represent mean ± s.e.m. of n ≥ 3 independent mouse experiments. For human results, n = 16 for non-DMs and n = 18 for DMs. NS = not significant, p ≥ 0.05. assessed using an unpaired, two-tailed Student’s t-test.